ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 83 filers reported holding ZAI LAB LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,301,644 | +86.8% | 159,400 | +77.1% | 0.08% | +102.6% |
Q4 2022 | $2,837,843 | +122.1% | 90,000 | +145.9% | 0.04% | +111.1% |
Q3 2022 | $1,278,000 | -83.9% | 36,600 | -71.1% | 0.02% | -78.0% |
Q4 2021 | $7,957,000 | -39.6% | 126,600 | +1.3% | 0.08% | -38.8% |
Q3 2021 | $13,174,000 | -39.0% | 125,000 | +2.5% | 0.13% | -36.5% |
Q2 2021 | $21,593,000 | +87.1% | 122,000 | +41.0% | 0.21% | +73.0% |
Q1 2021 | $11,542,000 | +160.8% | 86,500 | +164.5% | 0.12% | +139.2% |
Q4 2020 | $4,426,000 | -67.0% | 32,700 | -79.7% | 0.05% | -72.4% |
Q3 2020 | $13,407,000 | -6.8% | 161,200 | -7.9% | 0.18% | -9.3% |
Q2 2020 | $14,381,000 | +81.4% | 175,100 | +13.7% | 0.20% | +32.5% |
Q1 2020 | $7,928,000 | +57.8% | 154,000 | +27.5% | 0.15% | +92.5% |
Q4 2019 | $5,023,000 | +417.3% | 120,782 | +302.6% | 0.08% | +344.4% |
Q3 2019 | $971,000 | -72.2% | 30,000 | -70.0% | 0.02% | -70.0% |
Q2 2019 | $3,487,000 | +294.0% | 100,000 | +233.3% | 0.06% | +22.4% |
Q1 2019 | $885,000 | – | 30,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |